About SynDaver
SynDaver is a Healthcare company based in Tampa (United States) founded in 2004 by Christopher Sakezles. Synthetic human tissues, body parts, and cadavers. SynDaver has raised $1 million across 1 funding round. SynDaver has completed 1 acquisition, including Lifecast Body Simulation. Its chief executive, as recorded, is Christopher Sakezles. SynDaver offers products and services including Full Body Models, Organ Models, Skills Trainers, and Vascular Models. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is SynDaver Labs, Inc. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
SynDaver Labs was founded in 2004 in Tampa, United States, and operates in the medical simulation sector. Synthetic human cadavers, body parts, and tissues are manufactured using materials that replicate the properties of living human anatomy, including muscles, tendons, arteries, veins, and organs. These products are utilized in medical device testing, surgical training, clinical education, and military development to substitute for animal and human cadavers.
- Total Equity Funding$1M (USD)
in 1 rounds
- Latest Funding Round$1M (USD), Private Equity Round
Jul 2015
- Investments & Acquisitions
Products & Services of SynDaver
SynDaver offers a comprehensive portfolio of products and services, including Full Body Models, Organ Models, Skills Trainers, and Vascular Models.
Synthetic full-body replicas for medical training and simulation
Artificial organs for device testing and educational purposes
Interactive models for hands-on medical skill development
Synthetic vascular systems for surgical practice and research
Apps and channels of SynDaver
its YouTube channel syndaver has 2.77K subscribers and 30 videos.
Videos from SynDaver
The most watched videos on SynDaver's YouTube channel, syndaver (2.77K subscribers). Click a video to play it here.
More on syndaver.
Funding Insights of SynDaver
SynDaver has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $1 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 1
- Last Round Private Equity Round — $1M
- First Round $1M
(Jul 2015)
All 1 funding rounds of SynDaver with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2015 | $1M | Private Equity Round | – | – | – |
People of SynDaver
5 people are tracked at SynDaver (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Christopher Sakezles | Founder & CEO | Leadership |
Thomas Ewing | Vice President Global Sales & Marketing | Leadership |
Sam O. | Chief Operating Officer | Leadership |
Calisse Revilla | Director, Marketing & International Sales | Leadership |
Alan Doutre | Territory Sales Manager | Team |
Complete people profiles for SynDaver
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SynDaver
SynDaver has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lifecast Body Simulation.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medical training services are provided via lifelike body simulations. | lifecastbodysim.com | London, United Kingdom | 2017 | Jan 2018 | •••• |
Complete acquisition details for SynDaver
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SynDaver
3 dated milestones of SynDaver across 14 years, from founding to its latest funding, stage changes and deals.
- Founded SynDaver is founded.
- Funding First funding round of $1.0M.
- Acquisition Acquires Lifecast Body Simulation.
Competitors of SynDaver
SynDaver has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of SynDaver
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SynDaver
The website of SynDaver (syndaver.com) receives about 7.5K visits a month.
- Monthly visits7.5K
▼ 6.4% vs previous month
Websites whose visitors overlap most with SynDaver. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cstti.com | 100% | #5,591,156 | View details | ||
| limbsandthings.com | 97% | 25.5K | #1,011,045 | View details | |
synecorlabs.com | synecorlabs.com | 64% | – | ||
sufuorg.com | sufuorg.com | 61% | #3,078,774 | – | |
| bluephantom.com | 60% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for SynDaver
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SynDaver (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Syndaver
Complete news archive for SynDaver
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SynDaver
SynDaver was founded in 2004 and raised its 1st funding round 11 years after it was founded.
SynDaver is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Christopher Sakezles is the CEO of SynDaver, as recorded in our data. They have also founded this company.
SynDaver is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $1M, raised on Jul 2015.
SynDaver Labs was founded in 2004 in Tampa, United States, and operates in the medical simulation sector. Synthetic human cadavers, body parts, and tissues are manufactured using materials that replicate the properties of living human anatomy, including muscles, tendons, arteries, veins, and organs. These products are utilized in medical device testing, surgical training, clinical education, and military development to substitute for animal and human cadavers.
SynDaver's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
SynDaver offers Full Body Models, Organ Models, Skills Trainers, and Vascular Models.
SynDaver has made 1 acquisition, including Lifecast Body Simulation.
SynDaver operates through Syndaver Labs, Inc..